Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Is There an Association between Blood Group and Survival in Pancreatic Cancer?

  • Kos, F. Tugba (Department of Medical Oncology, Faculty of Medicine, Kahramanmaras Sutcu Imam University) ;
  • Civelek, Burak (Ankara Numune Education and Research Hospital) ;
  • Seker, M. Metin (Department of Medical Oncology, Cumhuriyet University Faculty of Medicine) ;
  • Arik, Zafer (Department of Medical Oncology, Hacettepe University Institute of Oncology) ;
  • Aksoy, Sercan (Department of Medical Oncology, Hacettepe University Institute of Oncology) ;
  • Uncu, Dogan (Ankara Numune Education and Research Hospital) ;
  • Ozdemir, Nuriye (Ankara Numune Education and Research Hospital) ;
  • Zengin, Nurullah (Ankara Numune Education and Research Hospital)
  • Published : 2012.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: An association between the ABO groups and pancreatic cancer has been shown previously, group A being significantly commoner in affected patients. We conducted the present study to investigate the prognostic effect of ABO blood group on overall survival of pancreas cancer patients. Methods: Patients who were diagnosed between 2005 and 2010 with pancreas cancer at Ankara Numune Education and Research Hospital were analyzed retrospectively. Patient demographics and ABO blood groups were obtained from medical charts. Results: Fifty pancreas cancer patients with known ABO blood group were included, 26 (52%) group A, 12 patients (24%) group 0, 9 (18%) group B, and 3 (6%) group AB. Blood group A pancreas cancer patient median age was 61.5 (39-80) years, with the median age of the other blood groups (B, AB,O) being 55.5 (32-74) years (p=0.14). 18% of patients with blood group A and 11% of the other blood group patients had metastasis (p=0.17) at the time of diagnosis. The median overall survival of blood group A pancreas patients was significantly lower than the other blood group patients, 7.6 (95%CI: 5.0-10.2) months versus 29.0 (95%CI: 0.0-68.8) months (p=0.05). Conclusions: Acccording to previously published cohort studies a relation may exist between ABO blood groups and cancer of pancreas. In this study we observed that pancreas cancer patients with blood group A have significantly worse overall survival than other blood groups.

Keywords

References

  1. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al (2009). Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet, 41, 986-90. https://doi.org/10.1038/ng.429
  2. Ben Q, Wang K, Yuan Y, Li Z (2011). Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer, 128, 1179-86. https://doi.org/10.1002/ijc.25426
  3. Conlon KC, Klimstra DS, Brennan MF (1996). Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg, 223, 273-9. https://doi.org/10.1097/00000658-199603000-00007
  4. Dandona M, Gao F, Linehan DC, Wang-Gillam A (2009). Re:ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 102, 135-7.
  5. Engin H, Bilir C, Ustun H, Gökmen A (2012). ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region. Asian Pac J Cancer Prev, 13, 131-3. https://doi.org/10.7314/APJCP.2012.13.1.131
  6. Greer JB, Yazer MH, Raval JS, et al (2010). Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol, 16, 5588-91. https://doi.org/10.3748/wjg.v16.i44.5588
  7. Hakomori S (1989). Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res, 52, 257-331. https://doi.org/10.1016/S0065-230X(08)60215-8
  8. Hakomori S (1999). Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta, 1473, 247-66. https://doi.org/10.1016/S0304-4165(99)00183-X
  9. Halvorsen TB (1986). ABO blood groups, rhesus types, and colorectal adenocarcinoma. A retrospective study of 747 cases. Scand J Gastroenterol, 21, 979-83. https://doi.org/10.3109/00365528608996408
  10. Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB (2010). ABO blood group and cancer. Eur J Cancer, 46, 3345-50. https://doi.org/10.1016/j.ejca.2010.08.009
  11. Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 59, 225-49. https://doi.org/10.3322/caac.20006
  12. Lowenfels AB, Maisonneuve P (2006). Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol, 20, 197-209. https://doi.org/10.1016/j.bpg.2005.10.001
  13. Slater G, Itzkowitz S, Azar S, Aufses AH Jr (1993). Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer. Dis Colon Rectum, 36, 5-7. https://doi.org/10.1007/BF02050293
  14. Wang DS, Wang ZQ, Zhang L, et al (2012). Are risk factors associated with outcomes in pancreatic cancer? PLoS One, 7, 41984. https://doi.org/10.1371/journal.pone.0041984
  15. Wolpin BM, Chan AT, Hartge P, et al (2009). ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 101, 424-31. https://doi.org/10.1093/jnci/djp020

Cited by

  1. ABO Blood Groups are Not Associated with Treatment Response and Prognosis in Patients with Local Advanced Non-Small Cell Lung Cancer vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3945
  2. The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China vol.35, pp.7, 2014, https://doi.org/10.1007/s13277-014-1960-7